Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage.
Tettenborn
D
D
Medical Department of Bayer AG, Wuppertal, FRG.
Dycka
J
J
D002545:Brain Ischemia / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D004311:Double-Blind Method; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications*; D015201:Meta-Analysis as Topic; D009553:Nimodipine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation; D012422:Rupture, Spontaneous; D013345:Subarachnoid Hemorrhage / Q000150:complications*
D009553:Nimodipine